Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
โ Scribed by Saffroy, R; Lelong, J-C; Azoulay, D; Salvucci, M; Reynes, M; Bismuth, H; Debuire, B; Lemoine, A
- Book ID
- 110000962
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 105 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Mutations of p53 can lead to the production of anti-p53 antibodies in sera of cancer patients. before this study, the value of preoperative serum anti-p53 antibodies in determining the prognoses of patients with gastric carcinoma had yet to be determined. ## Methods: The authors us
To clarify the clinical significance of the mutation of p53 gene in hepatocellular carcinoma (HCC), 90 resected specimens from Japanese patients were assayed using a polymerase chain reaction-single strand conformation polymorphism (PCRSSCP) analysis. p53 mutations were detected in 25 cases (27.8%)
## Background: For early detection of ulcerative colitis (uc)-associated colorectal cancer (crc), surveillance colonoscopy is recommended in uc patients at high risk. however, poor acceptability deteriorates its effectiveness and a suitable marker for selecting patients at high risk is needed. here
Annexin V has a calcium-dependent binding affinity for anionic phospholipids and activated platelets, and prevents prothrombinase activity. We investigated the clinical significance of IgG anti-annexin V antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera w
## BACKGROUND. Numerous clinical parameters have been suggested as predictors of outcome for patients with head and neck carcinoma treated with radiation therapy, but their applicability remains controversial. Inactivation of the p53 tumor suppressor results in radioresistance in experimental syst